The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient Mice

• Lisa-Mari Mörk ,

  Contributed equally to this work with: Lisa-Mari Mörk, Stefan Rehnmark

  * E-mail: lisa-mari.mork@ki.se

  Affiliation Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Stefan Rehnmark ,

  Contributed equally to this work with: Lisa-Mari Mörk, Stefan Rehnmark

  Current address: Axcentua Pharmaceuticals AB, Huddinge, Sweden

  Affiliation KaroBio AB, Stockholm, Sweden

  ⨯
• Padideh Davoodpour,

  Current address: Department of Medical and Health Sciences, Division of Cardiovascular Medicine, Linköping University, Linköping, Sweden

  Affiliation Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Giuseppe Danilo Norata,

  Affiliation Department of Pharmacological Sciences, Università degli Studi di Milano, Milan, Italy

  ⨯
• Lilian Larsson,

  Affiliation Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Michael-Robin Witt,

  Current address: Axcentua Pharmaceuticals AB, Huddinge, Sweden

  Affiliation KaroBio AB, Stockholm, Sweden

  ⨯
• Johan Malm,

  Current address: Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, Uppsala University, BMC, Uppsala, Sweden

  Affiliation KaroBio AB, Stockholm, Sweden

  ⨯
• Paolo Parini

  Affiliations Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden, Molecular Nutrition Unit, Department of Biosciences, Karolinska Institutet, Stockholm, Sweden

  ⨯